Skip to main content

and
  1. Article

    Open Access

    Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure

    Hendrik Nolte, Stephen R Durham, Harold S Nelson in Allergy, Asthma & Clinical Immunology (2014)

  2. Article

    Open Access

    Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

    Currently accepted therapies for ragweed allergy in North America consist of pharmacotherapy and subcutaneous allergen immunotherapy injections to treat symptoms. Allergen immunotherapy not only reduces sympto...

    Harold Kim, Susan Waserman, Jacques Hébert in Allergy, Asthma & Clinical Immunology (2014)

  3. Article

    Open Access

    The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

    The effect of sublingual Timothy grass immunotherapy tablet 2800 BAU (grass SLIT-T) has been evaluated in three North American trials in adults and children who have allergic rhinitis with or without conjuncti...

    Jacques Hébert, Michael Blaiss, Susan Waserman in Allergy, Asthma & Clinical Immunology (2014)